Silver Book Fact

A year-long study of patients with congestive heart failure found that increased use of medicines increased pharmaceutical costs by 60%; however, hospital costs declined by 78%, producing a net savings of $9.3 million. The ability of patients to perform activities of daily living went up 15% and the death rate dropped from an expected 25% to 10%.

Managed Healthcare. Provide Education About Congestive Heart Failure and Pump Up Your Savings; Mar-1998:42-4

Reference

Title
Provide Education About Congestive Heart Failure and Pump Up Your Savings
Publication Date
Mar-1998
Authors
Managed Healthcare
Volume & Issue
Volume 8, Issue 4
Pages
42-4

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Antihypertensive treatment has generated a benefit-to-cost ratio of at least 6:1 (6:1 in women and 10:1 in men).  
  • Initiating and continuing beta-blocker use in most first-time heart attack survivors for 20 years would result in 72,000 fewer coronary heart disease deaths, 62,000 fewer heart attacks, and 447,000 gained…  
  • Savings associated with t-PA treatment for ischemic stroke patients
    A $600 net savings is associated with each ischemic stroke patient treated with t-PA. In 2005, only 2% of all ischemic stroke patients received t-PA. If that percentage was increased…  
  • t-PA cost savings
    The total annual benefit to society from t-PA use in the United States is around $363 million—$60 million in direct cost savings to society plus an additional 7,510 QALYs. This means…  
  • Identifying individuals at high risk for developing AFib
    Using simple bedside measures, identification of individuals at risk for developing atrial fibrillation is feasible. Selecting high-risk individuals for inclusion in atrial fibrillation prevention trials may also enhance prevention strategies.